Gelesis Holdings, Inc. (GLSHQ)
USD 0.0
(-79.0%)
USD 0.0
(-79.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 103.32 Million USD | -29.38% |
| 2021 | 146.3 Million USD | 253.45% |
| 2020 | 41.39 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 114.5 Million USD | 1.71% |
| 2023 Q1 | 112.57 Million USD | -2.78% |
| 2022 FY | 103.32 Million USD | -29.38% |
| 2022 Q4 | 115.79 Million USD | -6.35% |
| 2022 Q1 | 131.13 Million USD | -71.75% |
| 2022 Q2 | 122.78 Million USD | -6.37% |
| 2022 Q3 | 123.63 Million USD | 0.7% |
| 2021 Q1 | 27.07 Million USD | -34.59% |
| 2021 FY | 146.3 Million USD | 253.45% |
| 2021 Q4 | 464.28 Million USD | 936.2% |
| 2021 Q3 | 44.8 Million USD | 44.48% |
| 2021 Q2 | 31.01 Million USD | 14.54% |
| 2020 Q4 | 41.39 Million USD | 0.0% |
| 2020 FY | 41.39 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -376541.271% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -991.537% |
| Evofem Biosciences, Inc. | 72.47 Million USD | -42.573% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -12675.07% |
| Rebus Holdings, Inc. | 5.24 Million USD | -1871.08% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | -75.084% |
| Qrons Inc. | 1.48 Million USD | -6840.492% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 1.22 Million USD | -8326.269% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | -37.912% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -231070.575% |
| Skye Bioscience, Inc. | 14.07 Million USD | -634.24% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | -93.835% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -978.311% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -24409.45% |
| SQZ Biotechnologies Company | 50.03 Million USD | -106.487% |
| Intellipharmaceutics International Inc. | 12 Million USD | -760.405% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -2582.748% |
| Mesoblast Limited | 188.44 Million USD | 45.17% |
| Marizyme, Inc. | 26.67 Million USD | -287.334% |
| Genus plc | 485 Million USD | 78.696% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -1668.453% |
| Pharming Group N.V. | 244.07 Million USD | 57.667% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -5040.165% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -4006.142% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -2619.053% |
| ContraFect Corporation | 32.53 Million USD | -217.617% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -5114.939% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -2599.412% |
| IMV Inc. | 37.93 Million USD | -172.387% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -777.248% |
| MultiCell Technologies, Inc. | 1617.67 USD | -6387111.236% |
| ONE Bio Corp. | 27.49 Million USD | -275.781% |
| Accustem Sciences Inc. | 1.07 Million USD | -9473.783% |
| RVL Pharmaceuticals plc | 77.41 Million USD | -33.464% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -4785.136% |
| Q BioMed Inc. | 8.13 Million USD | -1170.439% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | -24.584% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -1907.837% |
| Biomind Labs Inc. | 1.49 Million USD | -6794.647% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 12.97% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -1042.687% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -461.439% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -7105.998% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -72614.733% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -51275.326% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -1698.246% |
| GB Sciences, Inc. | 5.41 Million USD | -1807.207% |
| Alpha Cognition Inc. | 7.16 Million USD | -1342.111% |
| HST Global, Inc. | 593.59 Thousand USD | -17306.539% |
| CSL Limited | 18.62 Billion USD | 99.445% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -8105.573% |
| Halberd Corporation | 728.71 Thousand USD | -14078.854% |
| Enzolytics Inc. | 365.26 Million USD | 71.713% |
| Agentix Corp. | 2.51 Million USD | -4015.584% |
| Resverlogix Corp. | 67.39 Million USD | -53.309% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -12219.072% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | 76.779% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -5928.238% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -317.538% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -768.043% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -2719.083% |
| AVAX Technologies, Inc. | 3.99 Million USD | -2487.146% |
| Zenith Capital Corp. | 27.56 Thousand USD | -374683.271% |
| Genscript Biotech Corporation | 1.32 Billion USD | 92.207% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -43194.477% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -2666.886% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -15076.093% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -3710.386% |
| Kadimastem Ltd | 3.5 Million USD | -2848.015% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -154278.521% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | -105.563% |
| BioStem Technologies, Inc. | 15.9 Million USD | -549.646% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -22134.608% |
| LadRx Corporation | 2.2 Million USD | -4595.419% |
| Cell Source, Inc. | 15.8 Million USD | -553.672% |
| Regen BioPharma, Inc. | 5.45 Million USD | -1793.208% |
| Regen BioPharma, Inc. | 5.45 Million USD | -1793.208% |
| NovAccess Global Inc. | 7.86 Million USD | -1214.432% |
| Affymax, Inc. | 8.87 Million USD | -1064.739% |
| Itoco Inc. | 1.65 Million USD | -6150.125% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -4936.35% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -1608.117% |
| Mobile Lads Corp. | 1.31 Million USD | -7766.329% |
| CytoDyn Inc. | 127.89 Million USD | 19.211% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -247092.517% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -6496.369% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -835.458% |
| SYBLEU INC | 681.41 Thousand USD | -15063.198% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -1593.307% |
| International Stem Cell Corporation | 5.27 Million USD | -1858.006% |
| Bioxytran, Inc. | 3.24 Million USD | -3079.689% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -16410.469% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -2137.843% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -152.034% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -364.065% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -5001.445% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -1786.163% |
| Neutra Corp. | 973.52 Thousand USD | -10513.346% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -256.105% |
| PureTech Health plc | 125.58 Million USD | 17.725% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -2650.082% |
| IXICO plc | 1.9 Million USD | -5337.27% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -403.308% |
| CSL Limited | 18.62 Billion USD | 99.445% |
| Cellectis S.A. | 249.36 Million USD | 58.566% |